Real-World Experience with FcRn Inhibitors Efgartigimod and Rozanolixizumab in Myasthenia Gravis: Administration in Multiple Cycles and Transition from Intravenous to Subcutaneous FormulationMasaaki Yoshikawa, Haruki Koike, Toshihiro Ide et al.|Neurology and Therapy|2025Cited by 13
Efgartigimod Successfully Ameliorated Acute Exacerbation of Myasthenia Gravis with Anti-muscle-specific Kinase AntibodiesKoya Tanaka, Haruki Koike, Masaaki Yoshikawa et al.|Internal Medicine|2024Cited by 4
Characteristics of meningitis/encephalitis in adult patients with varicella-zoster virus infection: Experience from tertiary centers in Saga prefecture, JapanKeisuke Tsumura, Haruki Koike, Hiroshi Takashima et al.|Journal of the Neurological Sciences|2025Cited by 2